XML 32 R15.htm IDEA: XBRL DOCUMENT
v3.25.1

CASH AND CASH EQUIVALENTS AND MARKETABLE SECURITIES | 12 Months Ended
--- | ---
Dec. 31, 2024
Cash and Cash Equivalents [Abstract] |
CASH AND CASH EQUIVALENTS AND MARKETABLE SECURITIES | NOTE 3 – CASH AND CASH EQUIVALENTS AND MARKETABLE SECURITIES The following table sets forth our cash, cash equivalents and marketable securities as of December 31, 2024 and 2023: SCHEDULE OF CASH AND CASH EQUIVALENTS AND MARKETABLE SECURITIES
|  | As of December 31, |
|  | 2024 |  |  | 2023 |
Cash and cash equivalents: |  |  |  |  |  |  |  |
Cash |  | $ | 3,114 |  |  | $ | 2,468 |
Total cash and cash equivalents |  | $ | 3,114 |  |  | $ | 2,468 |
Marketable securities: |  |  |  |  |  |  |  |
Money market mutual funds |  | $ | 2,356 |  |  | $ | 1,420 |
U.S. treasury securities |  |  | - |  |  |  | 2,497 |
Total marketable securities |  | $ | 2,356 |  |  | $ | 3,917 |
Total cash, cash equivalents and marketable securities |  | $ | 5,470 |  |  | $ | 6,385 |
The unrealized gains on our marketable securities were $0 and $59 for the years ended December 31, 2024 and 2023, respectively. Treasuries have contractual maturities of less than 12 months. MICROBOT MEDICAL INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS U.S. dollars in thousands (Except share and per share data)

X
- References No definition available. + Details
Name: | us-gaap_CashAndCashEquivalentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure of cash, cash equivalents, and debt and equity securities, including any unrealized or realized gain (loss). + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 320 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/320/tableOfContent + Details
Name: | us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration